transient nausea) hospitalization length and frequency surgery or invasive intervention dialysis or long-term kidney impairment objective test confirmation (imaging, labs, motility studies) whether symptoms persist after stopping the drug long-term prognosis and disability lost income and impact on work capacity quality-of-life impairment The strongest compensation claims typically involve diagnosis + hospitalization + persistent impairment
The protective effect of GLP1-E2 as an add-on persisted for 5 weeks after treatment cessation, consistent with prior reports of sustained glycaemic benefits after GLP1-E2 discontinuation in non-autoimmune diabetes models [47]
Continue to drink plenty of fluids and eat regular meals while waiting to see if your symptoms subside
What causes the hippocampal volume decrease in depression
Hormonal changes and menstrual irregularities are commonly reported, raising questions about the drugs safety for female patients
This study aimed to understand the properties of tesofensine and M1 in mice, including how they are processed in the body (pharmacokinetics) and their effects (pharmacodynamics)
